Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Startup’s AI product set for wide distribution via major imaging vendor

One of the biggest imaging OEMs is offering healthcare providers using its radiography systems a third party’s AI toolset for detecting lung abnormalities.

Machine learning sees diseases obscured by info overload

Harvard researchers have demonstrated a way to cut through tangles of irrelevant information in electronic health records (EHRs) while applying machine learning to spot patterns indicative of specific disease markers.

Portable AI-enabled device brings blood testing to underserved areas

The device can also test for malaria and already has CE Mark approval as well as regulatory greenlights in India and Ghana.

Med student: Train us in AI now or watch quality suffer later

A medical student in the U.K. is cautioning proponents of AI in healthcare to beware the technology’s possible adverse effects on medical education.

Emergency-use authorization granted for AI-based COVID management

The FDA has cleared an AI startup based in Israel to market its predictive-analytics product to ICUs during the present pandemic.

Want to supercharge AI vs. COVID? Get more humans in the learning loop

For AI to make a truly damaging dent in COVID-19’s armor, developers need to better connect big-data analytics with regularly refreshed input from frontline healthcare workers.

AI helps diabetes patients manage glucose levels

In a pilot study of 16 patients, the system’s recommendations were deemed safe by expert endocrinologists at a clip of more than 99% over the course of four weeks.

Thumbnail

Machine learning predicts drug cardiotoxicity

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup